This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

NeoGenomics enlists Hague Convention to depose two UK researchers for US challenge

By Melissa Ritti ( December 10, 2024, 17:33 GMT | Insight) -- Infringement defendant NeoGenomics says two UK-based oncologists were wrongly omitted by Natera as inventors of cancer detection technology that NeoGenomics simultaneously argues is ineligible for patenting. So far, neither researcher has shown a willingness to be deposed.NeoGenomics wants to depose two London oncologists that it says were the first to invent a method for preparing a biological sample for monitoring the progression of cancer....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections